Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors

While developments in cancer therapeutics have greatly reduced morbidity and mortality in females with breast cancer, it comes at a cost of an increased risk of cardiovascular complications. In particular, anthracyclines, like doxorubicin, which are a mainstay of current chemotherapy regimens, are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Varghese, Sonu S., Johnston, Will J., Eekhoudt, Cameron R., Keats, Melanie R., Jassal, Davinder S., Grandy, Scott A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535000/
https://www.ncbi.nlm.nih.gov/pubmed/34677269
http://dx.doi.org/10.3390/curroncol28050351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535000/
https://www.ncbi.nlm.nih.gov/pubmed/34677269
http://dx.doi.org/10.3390/curroncol28050351

Ejemplares similares